Clinical trial · Interventional
CanMove: A Physical Activity Program for Children With Cancer
CanMove: The Feasibility of Implementing a Physical Activity Intervention for Children Undergoing Acute Cancer Treatment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will evaluate a physical activity intervention for children during acute cancer treatment. The intervention aims to encourage children to participate in increased levels of physical activity and reduce the amount of time they spend engaged in sedentary activities. This study also aims to evaluate different ways of assessing physical function in order to determine the best outcome measure to use for children during acute cancer treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Complex physical activity intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Physical Activity
- description
- Behavioural change techniques to promote physical activity
- interventionNames
- Behavioral: Complex physical activity intervention
Primary outcomes (17)
- measure
- Demand for the intervention
- timeFrame
- Through completion of recruitment, estimated as 9 months
- description
- Recruitment rate (comparing the number of people recruited to the number of potentially eligible participants), and documenting the reasons for non-participation.
- measure
- Acceptability of the intervention according to participants
- timeFrame
- After completion of the intervention (on average 8 weeks)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 5 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * Is between the ages of 5-17 years at the time of consent * Diagnosed (or relapsed) with cancer \>4 weeks and \<6 months at time of consent * Currently receiving cancer treatment at the Royal Children's Hospital * Has been an in-patient for \>7 consecutive days at the time of consent * Provide a signed and dated informed consent form and/or has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf Exclusion Criteria: * Deemed by the treating medical team as unsafe to participate * Child/adolescent unable to mobilise independent of clinical staff assistance, as classified by the research team at the time of consent (use of a gait aid or assistance from a primary carer/support person is accepted). For example, if a child/adolescent requires assistance from nursing staff or physiotherapist in order to walk, they will be excluded. * Child/adolescent unable to follow simple instructions * Suitable support person (18 years and over) not available to participate in continuous monitoring of daily steps in tandem with the child/adolescent * No suitable access to a device to sync with a Fitbit * Inability or unwillingness of participant or legally acceptable representative to give written informed consent.
References
Publications (1)
- BACKGROUNDBowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002. PMID 19362699